Antares Pharma, Inc. (ATRS) Financials

NASDAQ Currency in USD Disclaimer

$5.59

north_east NA Past Year
Day's range
$5.58
Day's range
$5.59
$200M$200M$150M$150M$100M$100M$50M$50M$0$0-$50M-$50MEarning2015201520162016201720172018201820192019202020202021202140%40%20%20%0%0%-20%-20%-40%-40%-60%-60%Profit Margin
Profit Margin
Revenue
Earnings

ATRS Income statement / Annual

Last year (2021), Antares Pharma, Inc.'s total revenue was $183.98 M, an increase of 22.98% from the previous year. In 2021, Antares Pharma, Inc.'s net income was $46.29 M. See Antares Pharma, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013 FY-2012
Period Ended 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Operating Revenue $183.98 M $149.60 M $123.86 M $63.55 M $54.52 M $52.22 M $45.66 M $26.50 M $20.62 M $22.58 M
Cost of Revenue $68.28 M $63.10 M $50.48 M $31.07 M $27.47 M $28.82 M $19.46 M $11.24 M $9.20 M $9.52 M
Gross Profit $115.70 M $86.50 M $73.39 M $32.49 M $27.05 M $23.41 M $26.20 M $15.26 M $11.42 M $13.06 M
Gross Profit Ratio 0.63 0.58 0.59 0.51 0.5 0.45 0.57 0.58 0.55 0.58
Research and Development Expenses $14.50 M $10.12 M $10.62 M $12.33 M $13.15 M $21.13 M $19.73 M $18.64 M $15.26 M $14.92 M
General & Administrative Expenses $0.00 $62.76 M $61.77 M $36.76 M $30.35 M $26.39 M $26.93 M $31.74 M $8.29 M $7.20 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $8.71 M $2.38 M
Selling, General & Administrative Expenses $73.86 M $62.76 M $61.77 M $36.76 M $30.35 M $26.39 M $26.93 M $31.74 M $17.01 M $9.59 M
Other Expenses $68.28 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $156.64 M $72.88 M $72.40 M $49.09 M $43.50 M $47.52 M $46.66 M $50.38 M $32.27 M $24.51 M
Cost And Expenses $224.92 M $135.98 M $122.87 M $80.16 M $70.97 M $76.34 M $66.12 M $61.61 M $41.47 M $34.03 M
Interest Income $0.00 $0.00 $0.00 $0.00 $0.00 $79,783.00 $60,469.00 $76,661.00 $111,577.00 $63,195.00
Interest Expense $0.00 $3.79 M $3.55 M $2.68 M $1.42 M $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $3.90 M $2.63 M $2.56 M $2.72 M $2.10 M $1.86 M $1.57 M $1.22 M $558,280.00 $231,028.00
EBITDA $66.17 M $16.34 M $4.08 M -$1.12 M -$13.22 M -$22.38 M -$18.91 M -$33.90 M -$20.25 M -$11.20 M
EBITDA Ratio 0.36 0.11 0.03 -0.02 -0.24 -0.43 -0.41 -1.28 -0.98 -0.5
Operating Income Ratio 0.34 0.09 0.01 -0.06 -0.3 -0.46 -0.45 -1.32 -1.01 -0.51
Total Other Income/Expenses Net $0.00 -$3.70 M -$3.02 M -$2.41 M -$292,000.00 -$122,344.00 -$21,867.00 -$13,420.00 $43,541.00 $24,049.00
Income Before Tax $62.27 M $9.92 M -$2.03 M -$6.52 M -$16.74 M -$24.24 M -$20.48 M -$35.13 M -$20.81 M -$11.43 M
Income Before Tax Ratio 0.34 0.07 -0.02 -0.1 -0.31 -0.46 -0.45 -1.33 -1.01 -0.51
Income Tax Expense $15.98 M -$46.28 M $530,000.00 $261,000.00 $1.13 M $100,000.00 $175,000.00 $25,000.00 -$300,000.00 $24,049.00
Net Income $46.29 M $56.20 M -$2.03 M -$6.52 M -$16.74 M -$24.34 M -$20.66 M -$35.15 M -$20.51 M -$11.43 M
Net Income Ratio 0.25 0.38 -0.02 -0.1 -0.31 -0.47 -0.45 -1.33 -0.99 -0.51
EPS 0.27 0.33 -0.01 -0.04 -0.11 -0.16 -0.14 -0.27 -0.16 -0.1
EPS Diluted 0.27 0.33 -0.01 -0.04 -0.11 -0.16 -0.14 -0.27 -0.16 -0.1
Weighted Average Shares Out $170.16 M $170.16 M $202.70 M $162.88 M $156.05 M $154.99 M $146.59 M $130.55 M $126.90 M $110.19 M
Weighted Average Shares Out Diluted $170.16 M $170.16 M $202.70 M $162.88 M $156.05 M $154.99 M $146.59 M $130.55 M $126.90 M $110.19 M
Link